INCOME TAXES (Details Narrative) |
12 Months Ended | ||
|---|---|---|---|
|
Oct. 31, 2023
USD ($)
|
Oct. 31, 2023
GBP (£)
|
Oct. 31, 2022
USD ($)
|
|
| Operating Loss Carryforwards [Line Items] | |||
| Research and development tax expenses | $ 158,883 | £ 174,771 | |
| Valuation allowance | $ 324,719 | ||
| UK [Member] | |||
| Operating Loss Carryforwards [Line Items] | |||
| Operating Loss Carryforwards | 477,271 | ||
| [custom:OperatingLossCarryforwardsIncludingTradingLoss-0] | 397,874 | ||
| [custom:OperatingLossCarryforwardsExcludingTradingLoss-0] | $ 79,397 | ||
| X | ||||||||||
- Definition Operating loss carryforwards excluding trading loss. No definition available.
|
| X | ||||||||||
- Definition Operating loss carryforwards including trading loss. No definition available.
|
| X | ||||||||||
- Definition Research and development tax expenses. No definition available.
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|